Validation of the Castle HTx data in a real world scenario

Back

EHRA 2024 Premium Access

Validation of the Castle HTx data in a real world scenario

Session: Atrial fibrillation: treatment 4 - ablation

Topic: Rhythm Control, Catheter Ablation

Speaker: Doctor C. Scheurlen (Cologne, DE)

Event: EHRA 2024

Congress Presentation

About the speaker

Doctor Cornelia Scheurlen

Heart Center at the University of Cologne, Cologne (Germany)

0 follower

8 more presentations in this session

Extended period rhythm outcomes of posterior box isolation of left atrium during pan-spectrum of atrial fibrillation catheter ablation in 4 randomized clinical trials

Speaker: Doctor S. Lee (Seoul, KR)

Predictive value of guideline-referred risk scores in estimating left atrial low voltage areas and recurrence of atrial fibrillation in repeat ablation procedures

Speaker: Doctor C. Georgi (Bernau, DE)

Long-term recurrence-free survival following second-generation cryoballoon ablation for persistent atrial fibrillation: role of the autonomic nervous system

Speaker: Doctor D. Guckel (Bad Oeynhausen, DE)

Radiofrequency balloon ablation: 1-year outcomes of the AURORA registry

Speaker: Doctor I. My (Hamburg, DE)

Effectiveness of a novel integrated dilator-needle transseptal crossing device in atrial fibrillation cryoballoon ablation procedures.

Speaker: Doctor J. Benezet Mazuecos (Madrid, ES)

Access the full session

Atrial fibrillation: treatment 4 - ablation

Speakers: Doctor C. Scheurlen, Doctor S. Lee, Doctor C. Georgi, Doctor D. Guckel, Doctor I. My...

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

Validation of the Castle HTx data in a real world scenario

About the speaker

Doctor Cornelia Scheurlen

8 more presentations in this session

Extended period rhythm outcomes of posterior box isolation of left atrium during pan-spectrum of atrial fibrillation catheter ablation in 4 randomized clinical trials

Predictive value of guideline-referred risk scores in estimating left atrial low voltage areas and recurrence of atrial fibrillation in repeat ablation procedures

Long-term recurrence-free survival following second-generation cryoballoon ablation for persistent atrial fibrillation: role of the autonomic nervous system

Radiofrequency balloon ablation: 1-year outcomes of the AURORA registry

Effectiveness of a novel integrated dilator-needle transseptal crossing device in atrial fibrillation cryoballoon ablation procedures.

Access the full session

Atrial fibrillation: treatment 4 - ablation

About the event

EHRA 2024

ESC 365 is supported by